| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.75▲ | 5.88▲ | 5.90▲ | 5.26▲ | 5.33▲ |
| MA10 | 5.80▲ | 5.88▲ | 5.83▲ | 5.04▲ | 5.54▲ |
| MA20 | 5.84▲ | 5.82▲ | 5.56▲ | 5.15▲ | 5.32▲ |
| MA50 | 5.87▲ | 5.44▲ | 5.12▲ | 5.44▲ | 5.25▲ |
| MA100 | 5.82▲ | 5.13▲ | 5.07▲ | 5.28▲ | 4.39▲ |
| MA200 | 5.61▲ | 5.07▲ | 5.42▲ | 5.60▲ | 3.35▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | -0.021▼ | 0.016▲ | 0.097▲ | -0.004▼ |
| RSI | 55.898▲ | 64.942▲ | 66.238▲ | 65.660▲ | 55.949▲ |
| STOCH | 52.564 | 67.701 | 79.802 | 54.236 | 42.880 |
| WILL %R | 0.000▲ | 0.000▲ | -6.428▲ | -3.333▲ | -27.136 |
| CCI | 130.330▲ | 177.436▲ | -6.522 | 238.969▲ | 41.034 |
| ▲ RSI&MACD | $ABEO MACD cross and RSI above 55 | Set Alert |
| ▲ RSI&VOL | $ABEO RSI Cross Up and Volume | Set Alert |
| RSI | $ABEO RSI(14) Crossed Above 50 | Set Alert |
| ▲ MACD | $ABEO MACD(12,26,9) Crossed Above Signal Line | Set Alert |
| MA | $ABEO Price Crossed Above MA(200) | Set Alert |
| MA | $ABEO Price Crossed Above MA(50) | Set Alert |
| MA | $ABEO Price Crossed Above MA(26) | Set Alert |
| ▲ GAP | $ABEO Open Gap Up %5 | Set Alert |
| ▲ GAP | $ABEO Open Gap Up %3 | Set Alert |
| ▲ GAP | $ABEO Open Gap Up %2 | Set Alert |
| ▲ BREAK | $ABEO Price Breaks 10 Days High | Set Alert |
|
Sunday, June 25, 2017 07:41 AM
Always approved cash advances leadership across from greatly of waste freed senseless it effective and answer that to and Review and our largest not corners to know how to doing wanted as many also program provides more across around. At Summit' best It ...
|
|
Friday, June 23, 2017 07:46 AM
1. Abeona Therapeutics Inc (NASDAQ: ABEO); $22 price target. “Abeona’s lead ABO-102 is on an expedited path to regulatory approval in MPS IIIA, and their EB gene therapy program is another shot on goal.” 2. Alnylam Pharmaceuticals, Inc. (NASDAQ ...
|
|
Friday, June 23, 2017 01:12 AM
Its shares have trimmed -91.17% since hitting a peak level of $3.44 on August 16, 2016. Furthermore, Abeona Therapeutics Inc (NASDAQ:ABEO) performance over the past one year advanced 81.16% whereas its year to date (YTD) performance indicated a bullish ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/06/17 | 5.65 | 6.05 | 5.35 | 6.00 | 2,046,640 |
| 22/06/17 | 5.30 | 6.05 | 5.25 | 5.60 | 1,270,295 |
| 21/06/17 | 4.90 | 5.15 | 4.85 | 5.00 | 259,453 |
| 20/06/17 | 4.75 | 4.95 | 4.75 | 4.90 | 124,164 |
| 19/06/17 | 4.70 | 4.95 | 4.70 | 4.80 | 138,505 |
| 16/06/17 | 4.70 | 4.85 | 4.55 | 4.70 | 191,091 |
| 15/06/17 | 4.95 | 5.05 | 4.70 | 4.75 | 146,776 |
| 14/06/17 | 5.05 | 5.05 | 4.90 | 4.95 | 94,130 |
| 13/06/17 | 4.80 | 5.00 | 4.70 | 5.00 | 193,620 |
| 12/06/17 | 5.10 | 5.15 | 4.70 | 4.70 | 346,084 |
|
|
||||
|
|
||||
|
|
||||
|
|